Temat: "ACUTE MYELOID-LEUKEMIA" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Unmet Horizons: Assessing the Challenges in the Treatment of TP53 -Mutated Acute Myeloid Leukemia.
Autorzy:: Stafylidis C; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vlachopoulou D; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Kontandreopoulou CN; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Diamantopoulos PΤ; Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.; Pokaż więcej
Źródło:: Journal of clinical medicine [J Clin Med] 2024 Feb 14; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
Autorzy:: Nagler A; Division of Hematology, Sheba Medical Center, Tel Hashomer, Israel. .
Labopin M; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France.; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
Blaise D; Programme de Transplantation and Therapie Cellulaire Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Raiola AM; Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Corral LL; Hospital Clínico Servicio de Hematología, Salamanca, Spain.
Bramanti S; Transplantation Unit Department of Oncology and Haematology, Istituto Clinico Humanitas, Milan, Italy.
Sica S; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy.
Kwon M; Hematology Hospital GU Gregorio Marañon, Instituto de Investigacion Sanitaria Gregorio Marañon, Medicina UCM, Madrid, Spain.
Koc Y; Bone Marrow Transplant Unit, Medicana International Hospital Istanbul, Istanbuls, Turkey.
Pavlu J; Department of Haematology, Hammersmith Hospital, Imperial College, London, UK.
Kulagin A; Raisa Gorbacheva Memorial, Research Institute for Paediatric Oncology, Hematology, and Transplantation, First State Pavlov Medical University of St. Petersburg, St. Petersburg, Russia.
Busca A; SSD Trapianto di Cellule Staminali, AOU Citta' Della Salute e della Scienza, Turin, Italy.
Rodríguez AB; Hospital U. Marqués de Valdecilla, Servicio de Hematología-Hemoterapia, Santander, Spain.
Reményi P; Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Department Hematology and Stem Cell Transplant, Budapest, Hungary.
Schmid C; Department of Hematology and Oncology, Augsburg University Hospital, Augsburg, Germany.
Brissot E; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Sorbonne University, and INSERM UMRs 938, Paris, France.
Sanz J; Hematology Department, Hospital Universitari Politècnic La Fe, Valencia, Spain.
Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Giebel S; Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Ciceri F; Ospedale San Raffaele, Haematology and BMT, Milan, Italy.
Mohty M; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France.; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2023 May 29; Vol. 16 (1), pp. 58. Date of Electronic Publication: 2023 May 29.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/methods
Leukemia, Myeloid, Acute*/complications
Graft vs Host Disease*/etiology
Adult ; Humans ; Middle Aged ; Transplantation, Haploidentical/methods ; Cyclophosphamide/therapeutic use ; Recurrence ; Transplantation Conditioning/methods ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML.
Autorzy:: Molica M; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
Perrone S; Hematology, Polo Universitario Pontino, S.M. Goretti Hospital, 04100 Latina, Italy.
Mazzone C; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
Cesini L; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
Canichella M; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.
de Fabritiis P; Hematology Unit, S. Eugenio Hospital, ASL Roma 2, 00144 Rome, Italy.; Department of Biomedicina and Prevenzione, Tor Vergata University, 00133 Rome, Italy.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2022 Jun 08; Vol. 14 (12). Date of Electronic Publication: 2022 Jun 08.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Landscape of FLT3 Variations Associated with Structural and Functional Impact on Acute Myeloid Leukemia: A Computational Study.
Autorzy:: Mirza Z; King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Al-Saedi DA; Department of Biochemistry, Faculty of Sciences, University of Tabuk, Tabuk 48322, Saudi Arabia.
Alganmi N; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Computer Science Department, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Karim S; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 18; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Journal Article
MeSH Terms:: fms-Like Tyrosine Kinase 3*/genetics
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Humans ; Molecular Docking Simulation ; Sorafenib/pharmacology ; Mutation ; Protein-Tyrosine Kinases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Differential Gene Regulatory Network Analysis between Azacitidine-Sensitive and -Resistant Cell Lines.
Autorzy:: Park H; School of Mathematics, Statistics and Data Science, Sungshin Women's University, Seoul 02844, Republic of Korea.
Miyano S; M&D Data Science Center, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.; Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 14; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Neuropeptides*/metabolism
Humans ; Azacitidine/pharmacology ; Azacitidine/therapeutic use ; Gene Regulatory Networks ; Cell Line, Tumor ; Metallothionein/genetics ; Metallothionein/metabolism ; GPI-Linked Proteins/metabolism ; RNA-Binding Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Treatment Outcomes of Adolescents Compared to Younger Pediatric Patients with Acute Myeloid Leukemia: Do They Need a Special Approach?
Autorzy:: Pawińska-Wąsikowska K; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.; Department of Pediatric Oncology and Hematology, University Children's Hospital, 30-663 Krakow, Poland.
Czogała M; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.; Department of Pediatric Oncology and Hematology, University Children's Hospital, 30-663 Krakow, Poland.
Bukowska-Strakova K; Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.
Surman M; Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.
Rygielska M; Department of Pediatric Oncology and Hematology, Hematology Laboratory, University Children's Hospital, 30-663 Krakow, Poland.
Książek T; Department of Medical Genetics, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.
Sadowska B; Department of Pediatric Oncology and Hematology, Cytogenetics and Molecular Genetics Laboratory, University Children's Hospital, 30-663 Krakow, Poland.
Pac A; Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Jagiellonian University Medical College, 31-034 Krakow, Poland.
Skalska-Sadowska J; Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, 60-572 Poznan, Poland.
Samborska M; Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, 60-572 Poznan, Poland.
Wachowiak J; Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, 60-572 Poznan, Poland.
Ciebiera M; Department of Pediatric Oncohematology, Clinical Province Hospital of Rzeszow, 35-301 Rzeszow, Poland.; Department of Pediatrics, Institute of Medical Sciences, Medical College, University of Rzeszow, 35-310 Rzeszow, Poland.
Chaber R; Department of Pediatric Oncohematology, Clinical Province Hospital of Rzeszow, 35-301 Rzeszow, Poland.; Department of Pediatrics, Institute of Medical Sciences, Medical College, University of Rzeszow, 35-310 Rzeszow, Poland.
Tomaszewska R; Department of Pediatric Hematology and Oncology, Medical University of Silesia, 40-055 Katowice, Poland.
Szczepański T; Department of Pediatric Hematology and Oncology, Medical University of Silesia, 40-055 Katowice, Poland.
Zielezińska K; Department of Pediatrics, Hemato-Oncology and Gastroenterology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Urasiński T; Department of Pediatrics, Hemato-Oncology and Gastroenterology, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
Moj-Hackemer M; Clinical Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland.
Kałwak K; Clinical Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, 213 Borowska St., 50-556 Wroclaw, Poland.
Kozłowska M; Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Irga-Jaworska N; Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Sikorska-Fic B; Department of Oncology, Pediatric Hematology, Transplantology and Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland.
Łaguna P; Department of Oncology, Pediatric Hematology, Transplantology and Pediatrics, Medical University of Warsaw, 02-091 Warsaw, Poland.
Muszyńska-Rosłan K; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-276 Bialystok, Poland.
Krawczuk-Rybak M; Department of Pediatric Oncology and Hematology, Medical University of Bialystok, 15-276 Bialystok, Poland.
Fałkowska A; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-090 Lublin, Poland.
Drabko K; Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-090 Lublin, Poland.
Bobeff K; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, 91-738 Lodz, Poland.
Młynarski W; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, 91-738 Lodz, Poland.
Chodała-Grzywacz A; Department of Pediatric Hematology and Oncology, Regional Polyclinic Hospital in Kielce, 25-736 Kielce, Poland.
Karolczyk G; Department of Pediatric Hematology and Oncology, Regional Polyclinic Hospital in Kielce, 25-736 Kielce, Poland.
Mycko K; Department of Pediatrics and Hematology and Oncology, Province Children's Hospital, 10-561 Olsztyn, Poland.
Badowska W; Department of Pediatrics and Hematology and Oncology, Province Children's Hospital, 10-561 Olsztyn, Poland.
Bartoszewicz N; Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, 85-094 Bydgoszcz, Poland.
Styczyński J; Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, 85-094 Bydgoszcz, Poland.
Machnik K; Department of Pediatrics, Hematology and Oncology, City Hospital, 41-500 Chorzow, Poland.
Mizia-Malarz A; Department of Pediatrics, Medical University of Silesia, Upper Silesia Children's Care Health Centre, 40-752 Katowice, Poland.
Balwierz W; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.; Department of Pediatric Oncology and Hematology, University Children's Hospital, 30-663 Krakow, Poland.
Skoczeń S; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, 30-663 Krakow, Poland.; Department of Pediatric Oncology and Hematology, University Children's Hospital, 30-663 Krakow, Poland.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2024 Mar 14; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Uncovering the cellular and omics characteristics of natural killer cells in the bone marrow microenvironment of patients with acute myeloid leukemia.
Autorzy:: Zhang L; Science and Technology Innovation Center, The Fourth People's Hospital of Jinan, The Teaching Hospital of Shandong First Medical University, 50 Shifan Road, Tianqiao District, Jinan, 250031, Shandong, China. leisheng_.; National Health Commission (NHC) Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, 730000, China. leisheng_.
Sun Y; Department of Hematology, Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, China.
Xue CE; Department of Hematology, Langfang City Hospital of Traditional Chinese Medicine, Langfang, 065000, China.
Wang S; Department of Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
Xu X; Department of Hematology, Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, 650118, China.
Zheng C; Department of Hematology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, China.
Chen C; Department of Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, 350001, China. .
Kong D; Department of Hematology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250033, China. .; Pokaż więcej
Źródło:: Cancer cell international [Cancer Cell Int] 2024 Mar 14; Vol. 24 (1), pp. 106. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription.
Autorzy:: Du M; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Wang M; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Liu M; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, Duarte, CA, USA.
Fu S; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.
Lin Y; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Huo Y; Hematology Department, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Dong Rd., Zhengzhou, 450000, Henan Province, People's Republic of China.
Yu J; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China.; Institute of Hematology, Zhejiang University, Hangzhou, China.
Yu X; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Wang C; Hematology Department, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Dong Rd., Zhengzhou, 450000, Henan Province, People's Republic of China. .
Xiao H; Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. .; Institute of Hematology, Zhejiang University, Hangzhou, China. .; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. .
Wang L; Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Rd., Hangzhou, 310003, Zhejiang Province, People's Republic of China. .; Institute of Hematology, Zhejiang University, Hangzhou, China. .; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Mar 13; Vol. 43 (1), pp. 79. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Bridged Bicyclo Compounds, Heterocyclic*
Leukemia, Myeloid, Acute*/metabolism
Sulfonamides*
Animals ; Humans ; Mice ; CCAAT-Enhancer-Binding Protein-alpha/genetics ; CCAAT-Enhancer-Binding Protein-alpha/metabolism ; CCAAT-Enhancer-Binding Protein-alpha/therapeutic use ; Protein Isoforms ; Proto-Oncogene Proteins c-bcl-2/genetics ; Transcription Factor CHOP/genetics ; Unfolded Protein Response

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Venetoclax Resistance in Acute Myeloid Leukemia.
Autorzy:: Garciaz S; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France.
Hospital MA; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France.
Collette Y; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France.
Vey N; Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2024 Mar 08; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid Leukemia.
Autorzy:: Chen TT; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Lin CC; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.; Division of Hematology and Oncology, Department of Internal Medicine, An Nan Hospital, Tainan 700, Taiwan.
Lo WJ; College of Medicine, China Medical University, Taichung 404, Taiwan.
Hsieh CY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.; Division of Hematology and Oncology, Department of Internal Medicine, An Nan Hospital, Tainan 700, Taiwan.
Lein MY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Lin CH; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Lin CY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.
Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.; Division of Hematology and Oncology, Department of Internal Medicine, An Nan Hospital, Tainan 700, Taiwan.
Chiu CF; Stem Cell Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan.
Yeh SP; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2024 Mar 07; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 07.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Phenotypic Analysis of Hematopoietic Stem and Progenitor Cell Populations in Acute Myeloid Leukemia Based on Spectral Flow Cytometry, a 20-Color Panel, and Unsupervised Learning Algorithms.
Autorzy:: Matthes T; Hematology Service, Oncology Department, University Hospital Geneva, Rue Gabrielle Perret-Gentil, 1205 Geneva, Switzerland.; Clinical Pathology Service, Diagnostics Department, University Hospital Geneva, Rue Gabrielle Perret-Gentil, 1205 Geneva, Switzerland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 29; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/drug therapy
Hematopoietic Stem Cell Transplantation*/methods
Humans ; Flow Cytometry/methods ; Unsupervised Machine Learning ; Hematopoietic Stem Cells/pathology ; Neoplasm, Residual/diagnosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia.
Autorzy:: Matsumura R; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Mochizuki S; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Morishita Y; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.; Department of Pediatrics, Kochi University, Kochi 783-8505, Japan.
Hayakawa H; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Karakawa S; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Kawaguchi H; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Okada S; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.
Hyakuna N; Department of Pediatrics, University of the Ryukyus Hospital, Okinawa 903-0215, Japan.
Kobayashi M; Department of Pediatrics, Hiroshima University Hospital, Hiroshima 734-8551, Japan.; Japanese Red Cross Chugoku-Shikoku Block Blood Center, Hiroshima 730-0052, Japan.; Pokaż więcej
Źródło:: Hematology reports [Hematol Rep] 2024 Feb 26; Vol. 16 (1), pp. 98-105. Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Case Reports

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Meta‑analysis of the efficacy of venetoclax and azacitidine combination therapy and azacitidine monotherapy for treating acute myeloid leukemia.
Autorzy:: Xie Y; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.; Graduate School, The First Clinical College of Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.
Wei X; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.; Graduate School, The First Clinical College of Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.
Wang W; Graduate School, The First Clinical College of Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.
Liao C; Graduate School, The First Clinical College of Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.
Han P; Department of Orthopedics, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.
Yu Y; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi 046000, P.R. China.; Pokaż więcej
Źródło:: Experimental and therapeutic medicine [Exp Ther Med] 2024 Feb 26; Vol. 27 (4), pp. 164. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Paclitaxel mediates the PI3K/AKT/mTOR pathway to reduce proliferation of FLT3‑ITD AML cells and promote apoptosis.
Autorzy:: Su Y; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Wu M; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Zhou B; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Bai Z; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Pang R; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Liu Z; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.
Zhao W; Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.; Pokaż więcej
Źródło:: Experimental and therapeutic medicine [Exp Ther Med] 2024 Feb 23; Vol. 27 (4), pp. 161. Date of Electronic Publication: 2024 Feb 23 (Print Publication: 2024).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Preclinical Characterization of the Anti-Leukemia Activity of the CD33/CD16a/NKG2D Immune-Modulating TriNKET CC-96191.
Autorzy:: Lunn-Halbert MC; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Laszlo GS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Erraiss S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Orr MT; Immuno-Oncology Cellular Therapy Thematic Research Center, Bristol Myers Squibb, Seattle, WA 98109, USA.
Jessup HK; Immuno-Oncology Cellular Therapy Thematic Research Center, Bristol Myers Squibb, Seattle, WA 98109, USA.
Thomas HJ; Immuno-Oncology Cellular Therapy Thematic Research Center, Bristol Myers Squibb, Seattle, WA 98109, USA.
Chan H; Bristol Myers Squibb, San Diego, CA 92121, USA.
Jahromi MA; Bristol Myers Squibb, San Diego, CA 92121, USA.
Lloyd J; Bristol Myers Squibb, San Diego, CA 92121, USA.
Cheung AF; Dragonfly Therapeutics, Waltham, MA 02451, USA.
Chang GP; Dragonfly Therapeutics, Waltham, MA 02451, USA.
Dichwalkar T; Dragonfly Therapeutics, Waltham, MA 02451, USA.
Fallon D; Dragonfly Therapeutics, Waltham, MA 02451, USA.
Grinberg A; Dragonfly Therapeutics, Waltham, MA 02451, USA.
Rodríguez-Arbolí E; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC/CIBERONC), University of Seville, 41013 Seville, Spain.
Lim SYT; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Kehret AR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Huo J; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Cole FM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Scharffenberger SC; Molecular Medicine and Mechanisms of Disease (M3D) Ph.D. Program, University of Washington, Seattle, WA 98195, USA.
Walter RB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA 98195, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2024 Feb 22; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylation.
Autorzy:: Wan X; Children's Hospital of Soochow University, Suzhou, 215003, China.; Department of Pediatrics, The First Affiliated Hospital of Wannan Medical College, Wuhu, 24100, China.
Wang J; Institute of Pediatric Research, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, China.
Fang F; Institute of Pediatric Research, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, China.
Hu Y; Department of Hematology, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, Jiangsu, China.
Zhang Z; Institute of Pediatric Research, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, China.
Tao Y; Department of Hematology, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, Jiangsu, China.
Zhang Y; Children's Hospital of Soochow University, Suzhou, 215003, China.
Yu J; Children's Hospital of Soochow University, Suzhou, 215003, China.
Wu Y; Children's Hospital of Soochow University, Suzhou, 215003, China.; Department of Pediatrics, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China.
Zhou B; Children's Hospital of Soochow University, Suzhou, 215003, China.; Suzhou Hospital of AnHui Medical University, Suzhou, 234000, China.
Yin H; Institute of Pediatric Research, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, China.
Ma L; Children's Hospital of Soochow University, Suzhou, 215003, China.
Li X; Institute of Pediatric Research, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, China.
Zhuo R; Children's Hospital of Soochow University, Suzhou, 215003, China.
Cheng W; Children's Hospital of Soochow University, Suzhou, 215003, China.; Department of Pediatrics, The First Affiliated Hospital of Wannan Medical College, Wuhu, 24100, China.
Zhang S; Children's Hospital of Soochow University, Suzhou, 215003, China.; Department of Pediatrics, The First Affiliated Hospital of Wannan Medical College, Wuhu, 24100, China.
Pan J; Institute of Pediatric Research, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, China. .
Lu J; Department of Hematology, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, Jiangsu, China. drlujun_.
Hu S; Department of Hematology, Children's Hospital of Soochow University, No.92 Zhongnan Street, SIP, Suzhou, 215003, Jiangsu, China. .; Pokaż więcej
Źródło:: Cancer cell international [Cancer Cell Int] 2024 Feb 22; Vol. 24 (1), pp. 81. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Acute myeloid leukemia with unreported translocation (x; 3) (q24; p13): A case report.
Autorzy:: Gholami N; Hematology and Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran.
Khalaji A; Connective Tissue Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.; Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran.
Mehri M; Hematology and Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran.; Department of Medical Genetics Tabriz University of Medical Sciences Tabriz Iran.
Mehrtabar S; Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran.; Student Research Committee Tabriz University of Medical Sciences Tabriz Iran.
Habibzade E; Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran.; Pokaż więcej
Źródło:: Clinical case reports [Clin Case Rep] 2024 Feb 20; Vol. 12 (2), pp. e8543. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
Typ publikacji:: Case Reports

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
Autorzy:: Feng S; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Yuan Y; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Lin Z; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Li M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Ye D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Shi L; Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, Zhejiang Province, China.
Li D; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Zhao M; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Meng C; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
He X; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Wu S; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China.
Xiong F; The Children's Hospital of Zhejiang University School of Medicine, 3333 Binsheng Road, Hangzhou, 310051, Zhejiang Province, China.
Ye S; School of Marine Sciences, Ningbo University, 818 Fenghua Road, Jiangbei District, Ningbo, Zhejiang Province, China.
Yang J; Department of Laboratory Medicine, The Second Affiliated Hospital, Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China.
Zhuang H; Department of Clinical Hematology and Transfusion, The First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Post Road, Hangzhou, Zhejiang Province, China.
Hong L; Department of Clinical Hematology and Transfusion, The First Affiliated Hospital of Zhejiang Chinese Medical University, 54 Post Road, Hangzhou, Zhejiang Province, China. .
Gao S; Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, 1 Xuefubei Street, Ouhai District, Wenzhou, 325000, Zhejiang Province, China. .; The Key Laboratory of Pediatric Hematology and Oncology Diseases of Wenzhou, the Second Affiliated Hospital, Yuying Children's Hospital of Wenzhou Medical University, 109 Xuanyuanxi Road, Wenzhou, Zhejiang Province, China. .; Pokaż więcej
Źródło:: Experimental hematology & oncology [Exp Hematol Oncol] 2024 Feb 20; Vol. 13 (1), pp. 19. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting.
Autorzy:: Gong X; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
He X; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Wang L; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Yu T; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.
Liu W; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Xu H; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Jin L; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Li X; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China.
Zhang B; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA. .
Tao Z; Department of Clinical Laboratory, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, Zheijang, P.R. China. .
Qian W; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China. .; Pokaż więcej
Źródło:: Experimental hematology & oncology [Exp Hematol Oncol] 2024 Feb 16; Vol. 13 (1), pp. 17. Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Letter

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells.
Autorzy:: Jramne-Saleem Y; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
Danilenko M; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 14; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Journal Article
MeSH Terms:: Transcription Factor AP-1*/metabolism
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/metabolism
Abietanes*
Humans ; NF-E2-Related Factor 2/metabolism ; Antioxidants/pharmacology ; Vitamin D/therapeutic use ; Vitamins/pharmacology ; Receptors, Calcitriol/metabolism ; Cell Differentiation ; Signal Transduction ; Glutathione/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""ACUTE MYELOID-LEUKEMIA"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język